Diabetes Clinical Trials
Here are the 6 most popular medical studies for diabetes
Mesenchymal Stem Cells
Cellular Therapy for Type 1 Diabetes
This trial will test whether fresh, donor-derived mesenchymal stem cells can safely and effectively treat new-onset type 1 diabetes. If successful, this could provide a new therapeutic option for patients with this and other autoimmune disorders.
Sulfonylurea
Insulin + Glyburide + Metformin for Gestational Diabetes
This trial will investigate whether an individualized treatment approach for gestational diabetes, based on each woman's specific mechanism for the condition, is more effective than the current standard approach.
Behavioural Intervention
Yoga Program and Running Program for Fuel Metabolism
This trial is testing how different types of exercise affect how the body processes fat and how this affects insulin resistance. It is looking specifically at the effects of weight and training on insulin resistance. The trial will study people before and after supervised aerobic or yoga training and test these differences using stable isotopes.
Continuous Glucose Monitoring Device
Continuous Glucose Monitoring for Diabetes
This trial will test whether or not systematic continuous glucose monitoring is an effective treatment option for patients with diabetes who are receiving care in a hospital setting.
Popular filter options for diabetes trials
Type 2 Diabetes Clinical Trials
View 54 Type 2 Diabetes medical studies.
Various Interventions for Diabetes
This trial tests components of an online intervention to help women with GDM get postpartum screening and programs for diabetes prevention. It mixes standard health info with motivational and logistical help. It uses a randomized factorial study design.
T2D Clinical Trials
View 44 T2D medical studies.
Various Interventions for Diabetes
This trial tests components of an online intervention to help women with GDM get postpartum screening and programs for diabetes prevention. It mixes standard health info with motivational and logistical help. It uses a randomized factorial study design.
Phase 3 Diabetes Clinical Trials
View 100 phase 3 diabetes medical studies.
Pulsed Acoustic Cellular Expression Device
dermaPACE® Device + Standard of Care for Diabetic Foot Ulcers
This trial is testing whether a sound wave device can help heal diabetic foot ulcers. The device has not been approved for this use, so it is considered investigational. The trial will compare the device to a sham device to see if it is more effective.
Monoclonal Antibodies
Ustekinumab for Type 1 Diabetes
This trial will assess if Ustekinumab can decrease C-peptide decline in participants with recent onset type 1 diabetes, in order to see if the drug is effective in protecting insulin-producing cells.
Diabetes Clinical Trials With No Placebo
View 100 diabetes medical studies that do not have a placebo group.
Various Interventions for Diabetes
This trial tests components of an online intervention to help women with GDM get postpartum screening and programs for diabetes prevention. It mixes standard health info with motivational and logistical help. It uses a randomized factorial study design.
QPL + MES + TXT for Type 1 Diabetes
This trial will test a new intervention to help 16-21 year olds with Type 1 Diabetes better manage their disease. The intervention is based on the idea that if these young adults feel more in control and supported, they will be more likely to stick to their care routine. If successful, this intervention could be used to help other groups manage chronic illnesses.
Nutrition Intervention
Dietary Intervention for Gestational Diabetes in South Asian Women
This trial will assess the impact of a culturally tailored, personalized nutrition intervention on glycemic response to an oral glucose load in high-risk pregnancies of South Asian women.
View More Diabetes Trials
See another 76 many medical studies focused on diabetes.
Frequently Asked Questions
Introduction to diabetes
What are the top hospitals conducting diabetes research?
When it comes to advancing the understanding and treatment of diabetes, several hospitals are making significant strides. In Birmingham, Alabama, the University of Alabama at Birmingham is actively involved in three diabetes trials, building on their dedication to this field since recording their first trial back in 2002. Similarly committed to research in Minneapolis is the University of Minnesotaf diabetes, several hospitals are making significant strides. In Birmingham, Alabama, the University of Alabama at Birmingham is actively involved in three diabetes trials, building on their dedication to this field since recording their first trial back in 2002. Similarly committed to research in Minneapolis is the University of Minnesota, where researchers are currently conducting three active trials for diabetes. While they have a shorter history with only one previous trial recorded in 2018, their efforts demonstrate a commitment to innovation and improvement.
Moving over to Bronx, New York City's Albert Einstein College of Medicine is also engaged in three ongoing clinical trials focused on diabetes. Although they do not yet have any completed trials listed under their name as an institution regarding this condition; however that does not diminish the importance or impact of their current work as it contributes toward expanding knowledge and improving treatments for individuals living with diabetes.
In Hamilton, Canada's McMaster University has embraced two active diabetes trials while having accomplished two previous investigations since initiating its pioneering study relatively recently - starting from 2013.These might seem like baby steps but these investigative endeavors demonstrate valuable contributions towards progressing our understanding about this widespread metabolic disorder.
Finally,, Brigham and Women's Hospital adds itself onto this list by actively participating into two such clinical tests .These Boston-based researchers initiated studies concerning Diabetes way back since recording its earliest trial on it being traced all way back to year 2007; accumulated experience through which already achieved five successful experiments till date- rendering them potential pioneer when compared against peers
Each hospital mentioned above plays an essential role in pushing forward our knowledge surrounding diabetes management and treatment options. By dedicating resources and expertise to these clinical trials, these institutions offer hope for those affected by this chronic condition while representing beacons guiding us towards future breakthroughs providing brighter perspectives for diabetics worldwide
Which are the best cities for diabetes clinical trials?
When it comes to diabetes clinical trials, several cities have emerged as key players in research and development. Aurora, Colorado leads the pack with 9 ongoing trials focusing on treatments like Semaglutide, Treatment order 1, and Tirzepatide Dose 2. Boston, Massachusetts follows closely behind with 8 active studies exploring interventions such as Semaglutide, Metformin, and Alert-based computerized decision support systems. Houston, Texas and Los Angeles, California to diabetes clinical trials, several cities have emerged as key players in research and development. Aurora, Colorado leads the pack with 9 ongoing trials focusing on treatments like Semaglutide, Treatment order 1, and Tirzepatide Dose 2. Boston, Massachusetts follows closely behind with 8 active studies exploring interventions such as Semaglutide, Metformin, and Alert-based computerized decision support systems. Houston, Texas and Los Angeles, California tie at 7 active trials each investigating a range of options including Insulin Efsitora Alfa, Dexcom G6 Professional Continuous Glucose Monitor use alongside Semaglutide or Tirzepatide Dose 2. Lastly, Birmingham in Alabama contributes to the research effort with its involvement in six different clinical trials examining various aspects of diabetes management. These cities offer individuals living with diabetes access to cutting-edge advancements through participation in these important clinical studies.
Which are the top treatments for diabetes being explored in clinical trials?
Groundbreaking research in diabetes is paving the way for promising treatments, which are being extensively explored in clinical trials. Metformin, a well-established medication first listed in 2005, has become the focus of one active trial and boasts an impressive track record with 25 all-time trials dedicated to diabetes management. Another exciting innovation is the Dexcom G6 Professional Continuous Glucose Monitor - introduced just this year - currently under investigation in one ongoing trial. These advancements hold immense potential for revolutionizing diabetes care and improving quality of life for individuals living with this chronic condition.
What are the most recent clinical trials for diabetes?
Exciting developments in the field of diabetes research are bringing new possibilities for treatment and management. One recent clinical trial, Ritlecitinib, has entered Phase 2 and holds promise for individuals with diabetes. Additionally, Fish Oil Concentrate oral capsules have shown potential benefits in both Phase 1 and Phase 2 trials. Another intriguing avenue being explored is the use of active THC in diabetes patients, which has entered Phase 1 testing. The GOLO for Life® Plan (G4LP) combined with Release Supplement also presents a promising option as it progresses through Phase 2 trials. Lastly, MIB 626 is an investigational product that has reached Phase 2 testing specifically targeting diabetes treatment. With these exciting advancements on the horizon, there is renewed hope for those living with this complex condition.
What diabetes clinical trials were recently completed?
Recently, several clinical trials focused on diabetes have reached completion, marking significant progress in the field. These trials encompassed various aspects of diabetes research and treatment strategies. One notable trial investigated the efficacy of a novel drug in managing blood sugar levels among diabetic patients. Another trial explored the potential benefits of lifestyle interventions, such as diet and exercise modifications, in improving overall health outcomes for individuals with diabetes. The completion of these trials underscores ongoing efforts to enhance our understanding of diabetes and develop more effective approaches to its management.